← Leaderboards
Jan J Melenhorst
Cleveland Clinic Lerner Com-Cwru
$4,246,921
Attributed
$5,772,620
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,772,620 · 4
By mechanism
R01$4,130,483 · 2
P01$1,642,137 · 2
Top collaborators
- Frederic D Bushman5 shared
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorResponseFailureGenesMalignant NeoplasmsCellsSamplingT-LymphocyteSolid NeoplasmAntigensReceptorCessation Of LifeApoptosisProteinsImproved OutcomeMultiple MyelomaEnzymesReportingCancer CellEventAutomobile DrivingCd19 GeneClustered Regularly Interspaced Short Palindromic RepeatsClinical Trials
Grant awards (14)
Mechanisms of nuclear Mcl-1 mediated chemoresistance$368,288
R01 · FY2025 · CA · contact PI
Mechanisms of nuclear Mcl-1 mediated chemoresistance$349,874
R01 · FY2024 · CA · contact PI
Linking insertional mutagenesis and cell function to improve CAR T cell therapy$592,071
R01 · FY2023 · CA
Mechanisms of nuclear Mcl-1 mediated chemoresistance$360,922
R01 · FY2023 · CA · contact PI
Linking insertional mutagenesis and cell function to improve CAR T cell therapy$600,298
R01 · FY2022 · CA
Linking insertional mutagenesis and cell function to improve CAR T cell therapy$621,091
R01 · FY2021 · CA
Linking insertional mutagenesis and cell function to improve CAR T cell therapy$619,360
R01 · FY2020 · CA
Linking insertional mutagenesis and cell function to improve CAR T cell therapy$618,579
R01 · FY2019 · CA
Core C: Correlative Sciences PDCS/TCSL$506,950
P01 · FY2019 · CA · contact PI
Core B - Tissue acquisition, Processing and Pathology (TAPP) Core$234,320
P01 · FY2019 · CA · contact PI
Core C: Correlative Sciences PDCS/TCSL$15,407
P01 · FY2019 · CA · contact PI
Core C: Correlative Sciences PDCS/TCSL$504,946
P01 · FY2018 · CA · contact PI
Core B - Tissue acquisition, Processing and Pathology (TAPP) Core$212,916
P01 · FY2018 · CA · contact PI
Core C: Correlative Sciences PDCS/TCSL$167,598
P01 · FY2017 · CA · contact PI